Last reviewed · How we verify

NCT05642351: ESAD

Autobiographical Specificity

Completed Last updated 3 April 2026
What this trial tests

trial testing Autobiographical reminder in Memory in 39 participants. Completed in 6 March 2026.

Timeline
3 February 2023
Primary endpoint
6 March 2026
6 March 2026

Quick facts

Lead sponsorNantes University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment39
Start date3 February 2023
Primary completion6 March 2026
Estimated completion6 March 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Memory or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autobiographical memory is diminished in patients with Alzheimer's Disease and those with behavioral variant of frontotemporal dementia, and research has focused on the hampered ability of patients in retrieving specific memories. However, this study proposes a detailed methodology to provide a qualitative analysis of autobiographical specificity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. "Who am I?": Weakened sense of the self in patients with behavioral variant frontotemporal dementia.
    El Haj M, Kapogiannis D, Boutoleau-Bretonnière C. · · 2023 · PMID 37026915 · DOI 10.1097/md.0000000000033461

Verify or expand the search:

Other recruiting trials for Memory

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05642351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing